ERT Announces Appointment of New President and CEO
4 May 2011 | By The Scott Partnership
ERT, has appointed Jeffrey S. Litwin, as its new President and Chief Executive Officer and as a member of the board...
List view / Grid view
News
Thermo Fisher Scientific announces upgrade program for NanoDrop Instruments
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new upgrade program that includes the donation of reconditioned Thermo Scientific NanoDrop 1000 spectrophotometers to academic institutions in developing countries.
FDA approves linagliptin tablets for the treatment of type 2 diabetes
3 May 2011 | By OgilvyHealthPR
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.1 The FDA has approved linagliptin as a monotherapy…
Teva to acquire Cephalon in $6.8 billion transaction
2 May 2011 | By Cephalon, Inc.
Teva will acquire all of the outstanding shares of Cephalon for a total enterprise value of approximately $6.8 billion...
GE Healthcare to acquire cellular imaging company Applied Precision, Inc.
28 April 2011 | By College Hill Ltd
GE Healthcare, today announced it has reached an agreement to acquire Applied Precision, Inc...
Thermo Fisher Scientific to highlight new laboratory solutions during UK summer symposium
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a free summer symposium presenting the latest developments in laboratory solutions.
Johnson & Johnson to buy orthopedic device maker Synthes for $21.3 billion
28 April 2011 | By Johnson & Johnson
Johnson & Johnson and Synthes announce definitive merger agreement to create world’s most comprehensive orthopaedics business...
AstraZeneca and Pozen sue Dr Reddy’s over Vimovo patent
28 April 2011 | By POZEN Inc.
AstraZeneca and POZEN have filed a patent infringement lawsuit against Dr. Reddy's relating to VIMOVO(TM)...
Lilly and Medtronic announce drug-device collaboration for Parkinson’s Disease
27 April 2011 | By Eli Lilly & Company
Collaboration combines companies' expertise in neuroscience and targeted drug delivery...
FDA approves GSK’s Lamictal®XR™ (lamotrigine)
27 April 2011 | By GlaxoSmithKline
The FDA has approved Lamictal® XR™ (lamotrigine) Extended-Release Tablets for conversion to monotherapy...
Non-Hodgkin’s Lymphoma drug market set to double to $8.4 billion by 2019
27 April 2011 | By Decision Resources
Decision Resources suggests that growth will be driven by the launches of premium-priced therapies...
Daiichi Sankyo receives first market approval in Japan for LIXIANA®
26 April 2011 | By Daiichi Sankyo
LIXIANA® (Edoxaban) is a direct oral factor Xa inhibitor for the prevention of venous thromboembolism...
DiscoveRx announces a series of scientific outreach programmes
26 April 2011 | By
To promote leading edge cell-based and biochemical GPCR and Kinase assays to the European community...
Pfizer comments on ORAL Sync tofacitinib data
25 April 2011 | By Pfizer Inc.
Pfizer has commented on an abstract concerning the ORAL Sync Phase 3 study of tofacitinib in patients with rheumatoid arthritis...
Idera Pharmaceuticals delays initiation of Phase 2 clinical trial of IMO-2125 in treatment-naïve HCV patients
22 April 2011 | By Idera Pharmaceuticals, Inc.
Delay is based on preliminary data from a 26-week nonclinical toxicology study...
